Propanc Biopharma Inc (PPCH) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Propanc Biopharma Inc   (PPCH)


Propanc Biopharma Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Propanc Biopharma Inc's ROI in the fourth quarter of 2026?
Propanc Biopharma Inc recorded a cumulative net loss of $-19 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -145.39%.

Within the Healthcare sector 681 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 3427 to 4155.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 111.98 % 694.54 % - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 11 14 14 14
Return On Investment (TTM) -145.39 % -137.8 % -435.7 % -591.47 % -962.73 %
PPCH's Overall Ranking # 4155 # 3427 # 3266 # 4043 # 3953
Seq. Investment Change TTM -2.63 % -12.13 % 41.45 % 75.15 % 264.97 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -19 -18 -66 -63 -59

PPCH Company Profile >> Back to PPCH Roi Comparisons >> See Annual PPCH Return On Investment



Return On Investment PPCH's Ranking
Within: No.
Industry # 311
Sector # 682
Overall # 4155

Return On Investment Statistics
High Average Low
-137.52 %
-927.28 %
-3292.3 %
(Mar 31 2026)   (Mar 31 2025)







Financial Statements
Propanc Biopharma Inc's IV. Quarter Investments $ 13 Millions PPCH's Balance sheet
Propanc Biopharma Inc's IV. Quarter Income $ -5 Millions Quarterly PPCH's Income Statement
PPCH's Income by Division See PPCH's Income by Division


PPCH Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 13 14 -4 -3 -3
Y / Y Investment Growth -9.96 % - - - -
Net Income in Millions -19 -59 -2 -3 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment -149.07 % -419.28 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PPCH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PPCH's Competitors
Subscribers only: Roi for Propanc Biopharma Inc's Suppliers
Subscribers only: Return On Investment for PPCH's Customers

Other Ratios
PPCH's Roa PPCH's Inventory Turnover Ratio PPCH's Growth Rates PPCH's Dividend Statistics
PPCH's Profitability Ratios PPCH's Asset Turnover Ratio PPCH's Dividend Growth
PPCH's Roe PPCH's Valuation Ratios PPCH's Financial Strength Ratios PPCH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T05:09:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.